FDA Announces Submission of Proposed Information Collection for Blood and Blood Components Regulations

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to Current Good Manufacturing Practices and regulations for blood and blood components, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.